Stay updated on Ciforadenant Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Ciforadenant Safety and Efficacy Clinical Trial page.

Latest updates to the Ciforadenant Safety and Efficacy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical-trial record for the ciforadenant and atezolizumab study is now displayed, including its design, participant criteria, study locations, and outcome measures. The record indicates that the study is completed and is no longer recruiting participants.SummaryDifference58%

- Check18 days agoChange DetectedThe footer now shows site revision v3.8.0 instead of v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide notice was added announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe site revision label in the footer changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the study record remains unavailable on the 403 page.SummaryDifference0.2%

- Check60 days agoChange DetectedThe NCT02655822 study page now presents a 403 Forbidden error page instead of the study details. The standard header and navigation indicate restricted access, effectively replacing the study content with an error screen.SummaryDifference18%

Stay in the know with updates to Ciforadenant Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ciforadenant Safety and Efficacy Clinical Trial page.